Hybrigenics a biopharmaceutical company, engages in the research and development of drugs intended for cancer treatment.
Business Model:
Revenue: $257.6k
Employees: 1-1
Address: 3-5 impasse Reille
City: Paris
State: other
Zip: 75014
Country: FR
Hybrigenics a biopharmaceutical company, engages in the research and development of drugs intended for cancer treatment.
Contact Phone:
Contact Email:
Listed Exchange:
NYSE
IPO Date:
1/2/2008
Ticker Symbol:
ALHYG
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 12/2001 | Series B | 8 | $11.6M |
Medicis Capital Auriga Partners Apax Partners Lombard Odier Alafi Capital HealthCap Institute of Mental Health SOFINDEV Medicis Capital Auriga Partners Apax Partners Lombard Odier Alafi Capital |
3/2012 | Post-IPO Equity | $4.4M | 7/2017 | Post-IPO Equity | $7.9M | 10/2014 | Post-IPO Equity | 1 | $5.8M |
Crede CapitalGroup Crede CapitalGroup |
9/2009 | Post-IPO Equity | 1 | $7.3M |
Yorkville Advisors Yorkville Advisors |
4/2002 | Venture Round | $14.8M | 6/2000 | Series A | 3 | $8.5M |
HealthCap Auriga Partners Apax Partners |
10/2013 | Post-IPO Equity | 1 | $1.8M |
Pradeyrol Development Pradeyrol Development |
8/2017 | Unattributed | $8.1M | 3/2014 | Post-IPO Equity | 2 | $8.4M |
Life Sciences Partners Pradeyrol Development Life Sciences Partners Pradeyrol Development |
5/2009 | Unattributed | $7.3M |
Yorkville Advisors |
---|
Announced Date | Name | Price |
---|---|---|
4/2003 | Semaia Pharmaceuticals |
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|